Literature DB >> 21234776

Medulloblastoma and gliomatosis cerebri: rare brain tumors in multiple sclerosis patients.

Ana Alexandra Duarte Martins da Silva1, Sara Marta Pereira dos Santos Cavaco, Ricardo Jorge Ferreira Taipa, Pedro Ricardo Soares Pinto, Manuel Jorge Rocha Melo Pires.   

Abstract

The simultaneous appearance of both multiple sclerosis (MS) and central nervous system (CNS) tumors is relatively uncommon. Whether the co-existence of two diseases is due to chance alone or the result of a causal relationship is still a matter of debate. There is also controversy about the effect of long-term exposure of MS patients to immunomodulatory drugs on the incidence of cancer. This paper reports two cases of rare CNS tumors (i.e., medulloblastoma and gliomatosis cerebri) in adult MS patients. Our cases emphasize that when uncommon neurological features appear in patients with MS, brain magnetic resonance imaging (MRI) ought to be done and brain biopsy should be considered to exclude a concomitant CNS disorder. These procedures are essential for the differential diagnosis and early treatment.

Entities:  

Mesh:

Year:  2011        PMID: 21234776     DOI: 10.1007/s10072-010-0468-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  15 in total

1.  Anaplastic oligodendroglioma and gliomatosis type 2 in interferon-beta treated multiple sclerosis patients. Report of two cases.

Authors:  Sasa Sega; Alenka Horvat; Mara Popovic
Journal:  Clin Neurol Neurosurg       Date:  2005-12-27       Impact factor: 1.876

2.  Cause of death in patients attending multiple sclerosis clinics.

Authors:  A D Sadovnick; K Eisen; G C Ebers; D W Paty
Journal:  Neurology       Date:  1991-08       Impact factor: 9.910

3.  Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature.

Authors:  Sophie Taillibert; Catherine Chodkiewicz; Florence Laigle-Donadey; Massimo Napolitano; Stéphanie Cartalat-Carel; Marc Sanson
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

Review 4.  Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments.

Authors:  Anat Achiron; Yoram Barak; Mitchell Gail; Matilda Mandel; David Pee; Rajeev Ayyagari; Zeev Rotstein
Journal:  Breast Cancer Res Treat       Date:  2005-02       Impact factor: 4.872

5.  Glatiramer acetate-associated, CD30+, primary, cutaneous, anaplastic large-cell lymphoma.

Authors:  Monica M Madray; John F Greene; David F Butler
Journal:  Arch Neurol       Date:  2008-10

6.  Multiple cerebral gliomas in multiple sclerosis.

Authors:  T J Reagan; I S Freiman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-08       Impact factor: 10.154

Review 7.  Prospects of repair in multiple sclerosis.

Authors:  V Wee Yong
Journal:  J Neurol Sci       Date:  2009-02-01       Impact factor: 3.181

8.  Trends in survival and cause of death in Danish patients with multiple sclerosis.

Authors:  Henrik Brønnum-Hansen; Nils Koch-Henriksen; Egon Stenager
Journal:  Brain       Date:  2004-02-11       Impact factor: 13.501

9.  Gliomatous transformation and demyelinating diseases.

Authors:  M Anderson; B Hughes; M Jefferson; W T Smith; J A Waterhouse
Journal:  Brain       Date:  1980-09       Impact factor: 13.501

10.  Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.

Authors:  C F Lucchinetti; R H Gavrilova; I Metz; J E Parisi; B W Scheithauer; S Weigand; K Thomsen; J Mandrekar; A Altintas; B J Erickson; F König; C Giannini; H Lassmann; L Linbo; S J Pittock; W Brück
Journal:  Brain       Date:  2008-06-05       Impact factor: 13.501

View more
  2 in total

Review 1.  Concurrence of multiple sclerosis and brain tumors.

Authors:  Domenico Plantone; Rosaria Renna; Emilia Sbardella; Tatiana Koudriavtseva
Journal:  Front Neurol       Date:  2015-03-04       Impact factor: 4.003

2.  Multiple sclerosis and oligodendroglioma: an exceptional association.

Authors:  Ana Teresa Carvalho; Paulo Linhares; Lígia Castro; Maria José Sá
Journal:  Case Rep Neurol Med       Date:  2014-08-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.